Back to Top Skip to main content Skip to sub-navigation

MHS asks COVID-19 recovered to donate plasma for seriously ill

Woman wearing mask and PPE holding a bag of plasma Sarahi Wilson, a phlebotomist assigned to Naval Medical Center San Diego, sets up an apheresis machine for drawing plasma at NMCSD’s Blood Donation Center July 14. (U.S. Navy photo by Mass Communication Specialist 2nd Class Erwin Jacob V. Miciano)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program

The COVID-19 Convalescent Plasma (CCP) Collection Program is a Department of Defense effort to collect 10,000 units of CCP donated by members of the military community who have recovered from the disease. CCP will be used to treat critically ill patients and to support the development of an effective treatment against the disease. Eligible donors should contact the Armed Services Blood Program at https://www.militaryblood.dod.mil/Donors/COVID-19andBloodDonation.aspx to find a complete list of available collection centers.

Patients who have recovered from COVID-19 can expect a call from a military hospital or from the Armed Services Blood Program alerting them of the opportunity to donate their plasma to help critically ill patients recover. The calls are part of the Military Health System response to the pandemic.

“The ASBP celebrates those who have fully recovered from COVID-19. We are asking for you to consider donating plasma via apheresis or whole blood donation process to help give others a fighting chance,” said Army Col. Audra L. Taylor, ASBP division chief.

Blood collection agencies such as the Blood Centers of America, the American Red Cross, and the ASBP are collecting COVID-19 convalescent plasma, or CCP. Plasma collections based on MHS outreach follow safety guidelines set by the Food and Drug Administration.

The ASBP provides blood products to the MHS and helps meet demand within the Department of Defense, said Army Col. Jason Corley, director of the Army Blood Program. The CCP collected will help beneficiaries within the MHS, but it’s also a readiness issue, he said.

“If a donor donates today, it [the plasma] could be used in one of our garrison hospitals, or it could be sent aboard a Navy ship or to our forces in U.S. Central Command to make sure they have it on hand and are medically ready,” said Corley. Frozen plasma can last up to one year, he added. “It’s definitely a way to treat the force and protect the force.”

Representatives from military hospitals and the ASBP are calling recovered patients to inform them about donating plasma and explain donation requirements. Potential donors who have recovered from COVID-19 must be symptom-free for at least 14 days since they were last tested positive. The ASBP will test the donated plasma for SARS-CoV-2, the virus that causes COVID-19, antibodies and alert the donor with a written letter about the presence of such antibodies, Corley added. Those who are eligible may donate whole blood every eight weeks or plasma by apheresis more frequently based on blood donor center guidance and donor qualification.

The ASBP is collecting CCP donations at nearly all of its donor centers with the exception of the Pentagon Blood Donor Center. Donating plasma can take anywhere between 45 and 90 minutes, producing two to three units from one visit. Anyone who has questions about the MHS outreach effort to collect donated COVID-19 convalescent plasma can contact their local blood center by visiting the ASBP website.

“For those who have donated, whether for CCP or regular blood donations, we at the ASBP want to sincerely thank you for taking time to do that,” said Corley. “We encourage everyone, regardless of whether you’ve been COVID-positive or not, if you're interested in blood donation, please reach out to us. We always need help and we couldn't do this without our volunteers.”

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus
Showing results 1 - 12 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.